References
- Alary J., Gueraud F., Cravedi J. P. Fate of 4‐hydroxynonenal in vivo: disposition and metabolic pathways. Mol. Aspects Med. 2003a; 24(4–5)177–187, [PUBMED], [INFOTRIEVE], [CSA]
- Alary J., Fernandez Y., Debrauwer L., Perdu E., Gueraud F. Identification of intermediate pathways of 4‐hydroxynonenal metabolism in the rat. Chem. Res. Toxicol. 2003b; 16(3)320–327, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ambroziak W., Pietruszko R. Human aldehyde dehydrogenase: metabolism of putrescine and histamine. Alcohol., Clin. Exp. Res. 1987; 11(6)528–532, [CSA]
- Ambroziak W., Pietruszko R. Human aldehyde dehydrogenase. Activity with aldehyde metabolites of monoamines, diamines, and polyamines. J. Biol. Chem. 1991; 266(20)13011–13018, [PUBMED], [INFOTRIEVE]
- Ambroziak W., Izaguirre G., Pietruszko R. Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney. J. Biol. Chem. 1999; 274(47)33366–33373, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ang H. L., Duester G. Retinoic acid biosynthetic enzyme ALDH1 localizes in a subset of retinoid‐dependent tissues during xenopus development. Dev. Dyn. 1999; 215(3)264–272, [PUBMED], [INFOTRIEVE], [CSA]
- Awasthi S., Srivatava S. K., Piper J. T., Singhal S. S., Chaubey M., Awasthi Y. C. Curcumin protects against 4‐hydroxy‐2‐trans‐nonenal‐induced cataract formation in rat lenses. Am. J. Clin. Nutr. 1996; 64(5)761–766, [PUBMED], [INFOTRIEVE], [CSA]
- Baumgartner M. R., Hu C. A., Almashanu S., Steel G., Obie C., Aral B., Rabier D., Kamoun P., Saudubray J. M., Valle D. Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)‐pyrroline‐5‐carboxylate synthase. Hum. Mol. Genet. 2000; 9(19)2853–2858, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Berggren K., McCaffery P., Drager U., Forehand C. J. Differential distribution of retinoic acid synthesis in the chicken embryo as determined by immunolocalization of the retinoic acid synthetic enzyme, RALDH‐2. Dev. Biol. 1999; 210(2)288–304, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Borman L. S., Branda R. F. Nutritional folate deficiency in Chinese hamster ovary cells. I. Characterization of the pleiotropic response and its modulation by nucleic acid precursors. J. Cell. Physiol. 1989; 140(2)335–343, [PUBMED], [INFOTRIEVE]
- Bunting K. D., Townsend A. J. Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. Demonstration of aldophosphamide metabolism by the human cytosolic class 3 isozyme. J. Biol. Chem. 1996; 271(20)11891–11896, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bunting K. D., Lindahl R., Townsend A. J. Oxazaphosphorine‐specific resistance in human MCF‐7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J. Biol. Chem. 1994; 269(37)23197–23203, [PUBMED], [INFOTRIEVE]
- Butterfield D. A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta‐peptide. Trends Mol. Med. 2001; 7(12)548–554, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chambliss K. L., Gibson K. M. Succinic semialdehyde dehydrogenase from mammalian brain: subunit analysis using polyclonal antiserum. Int. J. Biochem. 1992; 24(9)1493–1499, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chambliss K. L., Gray R. G., Rylance G., Pollitt R. J., Gibson K. M. Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency. J. Inherit. Metab. Dis. 2000; 23(5)497–504, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Champion K. M., Cook R. J., Tollaksen S. L., Giometti C. S. Identification of a heritable deficiency of the folate‐dependent enzyme 10‐formyltetrahydrofolate dehydrogenase in mice. Proc. Natl. Acad. Sci. U. S. A. 1994; 91(24)11338–11342, [PUBMED], [INFOTRIEVE], [CSA]
- Chan W. M., Tang W. K., Cheng C. H., Fong W. P. Purification, N‐terminal sequence determination and enzymatic characterization of antiquitin from the liver of grass carp. Comp. Biochem. Physiol., Part B Biochem. Mol. Biol. 2003; 136(3)443–450, [CROSSREF], [CSA]
- Chao Y. C., Liou S. R., Chung Y. Y., Tang H. S., Hsu C. T., Li T. K., Yin S. J. Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology 1994; 19(2)360–366, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chern M. K., Pietruszko R. Human aldehyde dehydrogenase E3 isozyme is a betaine aldehyde dehydrogenase. Biochem. Biophys. Res. Commun. 1995; 213(2)561–568, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cook R. J., Lloyd R. S., Wagner C. Isolation and characterization of cDNA clones for rat liver 10‐formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 1991; 266(8)4965–4973, [PUBMED], [INFOTRIEVE]
- De Laurenzi V., Rogers G. R., Hamrock D. J., Marekov L. N., Steinert P. M., Compton J. G., Markova N., Rizzo W. B. Sjögren–Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat. Genet. 1996; 12(1)52–57, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Demozay D., Rocchi S., Mas J. C., Grillo S., Pirola L., Chavey C., Van Obberghen E. Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin. J. Biol. Chem. 2003; 279(8)6261–6270, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dib M., Garrel C., Favier A., Robin V., Desnuelle C. Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?. J. Neurol. 2002; 249(4)367–374, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dockham P. A., Lee M. O., Sladek N. E. Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem. Pharmacol. 1992; 43(11)2453–2469, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur. J. Biochem. 2000; 267(14)4315–4324, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dupe V., Matt N., Garnier J. M., Chambon P., Mark M., Ghyselinck N. B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. U. S. A. 2003; 100(24)14036–14041, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- el Akawi Z., Napoli J. L. Rat liver cytosolic retinal dehydrogenase: comparison of 13‐cis‐, 9‐cis‐, and all‐trans‐retinal as substrates and effects of cellular retinoid‐binding proteins and retinoic acid on activity. Biochemistry 1994; 33(7)1938–1943, [PUBMED], [INFOTRIEVE]
- Enomoto N., Takase S., Takada N., Takada A. Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase‐2 genes. Hepatology 1991; 13(6)1071–1075, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Eriksson C. J. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol., Clin. Exp. Res. 2001; 25(5 Suppl. ISBRA)15S–32S, [CROSSREF]
- Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4‐hydroxynonenal malondialdehyde and related aldehydes. Free Radic. Biol. Med. 1991; 11: 81–128, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fan X., Molotkov A., Manabe S., Donmoyer C. M., Deltour L., Foglio M. H., Cuenca A. E., Blaner W. S., Lipton S. A., Duester G. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol. Cell. Biol. 2003; 23(13)4637–4648, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Farrant R. D., Walker V., Mills G. A., Mellor J. M., Langley G. J. Pyridoxal phosphate de‐activation by pyrroline‐5‐carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. J. Biol. Chem. 2001; 276(18)15107–15116, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gibson K. M., Hoffmann G. F., Hodson A. K., Bottiglieri T., Jakobs C. 4‐Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 1998; 29(1)14–22, [PUBMED], [INFOTRIEVE], [CSA]
- Goedde H. W., Agarwal D. P. Pharmacogenetics of aldehyde dehydrogenase (ALDH). Pharmacol. Ther. 1990; 45(3)345–371, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Goedde H. W., Agarwal D. P., Fritze G., Meier‐Tackmann D., Singh S., Beckmann G., Bhatia K., Chen L. Z., Fang B., Lisker R. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum. Genet. 1992; 88(3)344–346, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Grun F., Hirose Y., Kawauchi S., Ogura T., Umesono K. Aldehyde dehydrogenase 6, a cytosolic retinaldehyde dehydrogenase prominently expressed in sensory neuroepithelia during development. J. Biol. Chem. 2000; 275(52)41210–41218, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gupta M., Greven R., Jansen E. E., Jakobs C., Hogema B. M., Froestl W., Snead O. C., Bartels H., Grompe M., Gibson K. M. Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma‐hydroxybutyric aciduria). J. Pharmacol. Exp. Ther. 2002; 302(1)180–187, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Haselbeck R. J., Hoffmann I., Duester G. Distinct functions for Aldh1 and Raldh2 in the control of ligand production for embryonic retinoid signaling pathways. Dev. Genet. 1999; 25(4)353–364, [PUBMED], [INFOTRIEVE], [CSA]
- Hashimoto Y., Nakayama T., Futamura A., Omura M., Nakarai H., Nakahara K. Relationship between genetic polymorphisms of alcohol‐metabolizing enzymes and changes in risk factors for coronary heart disease associated with alcohol consumption. Clin. Chem. 2002; 48(7)1043–1048, [PUBMED], [INFOTRIEVE], [CSA]
- Haynes R. L., Szweda L., Pickin K., Welker M. E., Townsend A. J. Structure‐activity relationships for growth inhibition and induction of apoptosis by 4‐hydroxy‐2‐nonenal in raw 264.7 cells. Mol. Pharmacol. 2000; 58(4)788–794, [PUBMED], [INFOTRIEVE], [CSA]
- Hjelle J. J., Petersen D. R. Metabolism of malondialdehyde by rat liver aldehyde dehydrogenase. Toxicol. Appl. Pharmacol. 1983; 70(1)57–66, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hogema B. M., Gupta M., Senephansiri H., Burlingame T. G., Taylor M., Jakobs C., Schutgens R. B., Froestl W., Snead O. C., Diaz‐Arrastia R., Bottiglieri T., Grompe M., Gibson K. M. Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat. Genet. 2001; 29(2)212–216, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hsu L. C., Chang W. C., Yoshida A. Human aldehyde dehydrogenase genes, ALDH7 and ALDH8: genomic organization and gene structure comparison. Gene 1997; 189(1)89–94, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ingelman‐Sundberg M., Daly A. K., Oscarson M., Nebert D. W. Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles. Pharmacogenetics 2000; 10(1)91–93, [CROSSREF], [CSA]
- Jester J. V., Moller‐Pedersen T., Huang J., Sax C. M., Kays W. T., Cavangh H. D., Petroll W. M., Piatigorsky J. The cellular basis of corneal transparency: evidence for ‘corneal crystallins’. J. Cell. Sci. 1999; 112(Pt. 5)613–622, [PUBMED], [INFOTRIEVE]
- Kamino K., Nagasaka K., Imagawa M., Yamamoto H., Yoneda H., Ueki A., Kitamura S., Namekata K., Miki T., Ohta S. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late‐onset Alzheimer's disease in the Japanese population. Biochem. Biophys. Res. Commun. 2000; 273(1)192–196, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Karna E., Miltyk W., Wolczynski S., Palka J. A. The potential mechanism for glutamine‐induced collagen biosynthesis in cultured human skin fibroblasts. Comp. Biochem. Physiol., Part B Biochem. Mol. Biol. 2001; 130(1)23–32, [CROSSREF], [CSA]
- Kelson T. L., Secor M., Jr., Rizzo W. B. Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization. Biochim. Biophys. Acta 1997; 1335(1–2)99–110, [PUBMED], [INFOTRIEVE]
- Krupenko S. A., Oleinik N. V. 10‐Formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down‐regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ. 2002; 13(5)227–236, [PUBMED], [INFOTRIEVE], [CSA]
- Krupenko S. A., Wagner C., Cook R. J. Domain structure of rat 10‐formyltetrahydrofolate dehydrogenase. Resolution of the amino‐terminal domain as 10‐formyltetrahydrofolate hydrolase. J. Biol. Chem. 1997; 272(15)10273–10278, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lin M., Napoli J. L. cDNA cloning and expression of a human aldehyde dehydrogenase (ALDH) active with 9‐cis‐retinal and identification of a rat ortholog, ALDH12. J. Biol. Chem. 2000; 275(51)40106–40112, [PUBMED], [INFOTRIEVE]
- Lin M., Zhang M., Abraham M., Smith S. M., Napoli J. L. Mouse retinal dehydrogenase 4 (RALDH4), molecular cloning, cellular expression, and activity in 9‐cis‐retinoic acid biosynthesis in intact cells. J. Biol. Chem. 2003; 278(11)9856–9861, [PUBMED], [INFOTRIEVE]
- Manzer R., Qamar L., Estey T., Pappa A., Petersen D. R., Vasiliou V. Molecular cloning and baculovirus expression of the rabbit corneal aldehyde dehydrogenase (ALDH1A1) cDNA. DNA Cell Biol. 2003; 22(5)329–338, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maxwell S. A., Davis G. E. Differential gene expression in p53‐mediated apoptosis‐resistant vs. apoptosis‐sensitive tumor cell lines. Proc. Natl. Acad. Sci. U. S. A. 2000; 97(24)13009–13014, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Miltyk W., Palka J. A. Potential role of pyrroline 5‐carboxylate in regulation of collagen biosynthesis in cultured human skin fibroblasts. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 2000; 125(2)265–271, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mitchell D. Y., Petersen D. R. The oxidation of alpha‐beta unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol. 1987; 87(3)403–410, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Murphy T. C., Amarnath V., Gibson K. M., Picklo M. J., Sr. Oxidation of 4‐hydroxy‐2‐nonenal by succinic semialdehyde dehydrogenase (ALDH5A). J. Neurochem. 2003; 86(2)298–305, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Muto M., Hitomi Y., Ohtsu A., Ebihara S., Yoshida S., Esumi H. Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut 2000; 47(2)256–261, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Niederreither K., McCaffery P., Drager U. C., Chambon P., Dolle P. Restricted expression and retinoic acid‐induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH‐2) gene during mouse development. Mech. Dev. 1997; 62(1)67–78, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Niederreither K., Subbarayan V., Dolle P., Chambon P. Embryonic retinoic acid synthesis is essential for early mouse post‐implantation development. Nat. Genet. 1999; 21(4)444–448, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Niederreither K., Vermot J., Schuhbaur B., Chambon P., Dolle P. Retinoic acid synthesis and hindbrain patterning in the mouse embryo. Development 2000; 127(1)75–85, [PUBMED], [INFOTRIEVE]
- Nishiguchi M., Kinoshita H., Mostofa J., Taniguchi T., Ouchi H., Minami T., Hatake K., Utsumi T., Motomura H., Hishida S. Different blood acetaldehyde concentration following ethanol administration in a newly developed high alcohol preference and low alcohol preference rat model system. Alcohol Alcohol. 2002; 37(1)9–12, [PUBMED], [INFOTRIEVE]
- Ohsawa I., Nishimaki K., Yasuda C., Kamino K., Ohta S. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J. Neurochem. 2003; 84(5)1110–1117, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ohta S. Roles of mitochondrial dysfunctions in Alzheimer's disease—contribution of deficiency of ALDH 2. Rinsho Shinkeigaku 2000; 40(12)1231–1233, [PUBMED], [INFOTRIEVE], [CSA]
- Oleinik N. V., Krupenko S. A. Ectopic expression of 10‐formyltetrahydrofolate dehydrogenase in a549 cells induces g(1) cell cycle arrest and apoptosis. Mol. Cancer Res. 2003; 1(8)577–588, [PUBMED], [INFOTRIEVE], [CSA]
- Pappa A., Estey T., Manzer R., Brown D., Vasiliou V. Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea. Biochem. J. 2003a; 376(Pt. 3)615–623, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pappa A., Chen C., Koutalos Y., Townsend A. J., Vasiliou V. Aldh3a1 protects human corneal epithelial cells from ultraviolet‐ and 4‐hydroxy‐2‐nonenal‐induced oxidative damage. Free Radic. Biol. Med. 2003b; 34(9)1178–1189, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Parekh H. K., Sladek N. E. NADPH‐dependent enzyme‐catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide. Biochem. Pharmacol. 1993; 46(6)1043–1052, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pearl P. L., Gibson K. M., Acosta M. T., Vezina L. G., Theodore W. H., Rogawski M. A., Novotny E. J., Gropman A., Conry J. A., Berry G. T., Tuchman M. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 2003; 60(9)1413–1417, [PUBMED], [INFOTRIEVE]
- Picklo M. J., Olson S. J., Markesbery W. R., Montine T. J. Expression and activities of aldo‐keto oxidoreductases in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001; 60(7)686–695, [PUBMED], [INFOTRIEVE], [CSA]
- Reichard J. F., Vasiliou V., Petersen D. R. Characterization of 4‐hydroxy‐2‐nonenal metabolism in stellate cell lines derived from normal and cirrhotic rat liver. Biochim. Biophys. Acta 2000; 1487(2–3)222–232, [PUBMED], [INFOTRIEVE]
- Rekha G. K., Devaraj V. R., Sreerama L., Lee M. J., Nagasawa H. T., Sladek N. E. Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by chlorpropamide analogues. Biochem. Pharmacol. 1998; 55(4)465–474, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ren S., Yang J. S., Kalhorn T. F., Slattery J. T. Oxidation of cyclophosphamide to 4‐hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes. Cancer Res. 1997; 57(19)4229–4235, [PUBMED], [INFOTRIEVE]
- Reuland S. N., Vlasov A. P., Krupenko S. A. Disruption of a calmodulin central helix‐like region of 10‐formyltetrahydrofolate dehydrogenase impairs its dehydrogenase activity by uncoupling the functional domains. J. Biol. Chem. 2003; 278(25)22894–22900, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rizzo W. B., Carney G., Liu Z. The molecular basis of Sjögren‐Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am. J. Hum. Genet. 1999; 65(6)1547–1560, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roe C. R., Struys E., Kok R. M., Roe D. S., Harris R. A., Jakobs C. Methylmalonic semialdehyde dehydrogenase deficiency: psychomotor delay and methylmalonic aciduria without metabolic decompensation. Mol. Genet. Metab. 1998; 65(1)35–43, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Saito K., Yokoyama T., Yoshiike N., Date C., Yamamoto A., Muramatsu M., Tanaka H. Do the ethanol metabolizing enzymes modify the relationship between alcohol consumption and blood pressure?. J. Hypertens. 2003; 21(6)1097–1105, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sayre L. M., Smith M. A., Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 2001; 8(7)721–738, [PUBMED], [INFOTRIEVE]
- Siu G. M., Draper H. H. Metabolism of malonaldehyde in vivo and in vitro. Lipids 1982; 17(5)349–355, [PUBMED], [INFOTRIEVE]
- Skvorak A. B., Robertson N. G., Yin Y., Weremowicz S., Her H., Bieber F. R., Beisel K. W., Lynch E. D., Beier D. R., Morton C. C. An ancient conserved gene expressed in the human inner ear: identification, expression analysis, and chromosomal mapping of human and mouse antiquitin (ATQ1). Genomics 1997; 46(2)191–199, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sladek N. E. Aldehyde dehydrogenase‐mediated cellular relative insensitivity to the oxazaphosphorines. Curr. Pharm. Des. 1999; 5(8)607–625, [PUBMED], [INFOTRIEVE], [CSA]
- Sophos N. A., Vasiliou V. Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem. Biol. Interact. 2003; 143–144: 5–22, [CROSSREF]
- Sophos N. A., Pappa A., Ziegler T. L., Vasiliou V. Aldehyde dehydrogenase gene superfamily: the 2000 update. Chem. Biol. Interact. 2001; 130–132(1–3)323–337, [CROSSREF]
- Spence J. P., Liang T., Eriksson C. J., Taylor R. E., Wall T. L., Ehlers C. L., Carr L. G. Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populations. Alcohol., Clin. Exp. Res. 2003; 27(9)1389–1394, [CROSSREF]
- Sreerama L., Rekha G. K., Sladek N. E. Phenolic antioxidant‐induced overexpression of class‐3 aldehyde dehydrogenase and oxazaphosphorine‐specific resistance. Biochem. Pharmacol. 1995; 49(5)669–675, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stewart M. J., Malek K., Xiao Q., Dipple K. M., Crabb D. W. The novel aldehyde dehydrogenase gene, ALDH5, encodes an active aldehyde dehydrogenase enzyme. Biochem. Biophys. Res. Commun. 1995; 211(1)144–151, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Swindell E. C., Thaller C., Sockanathan S., Petkovich M., Jessell T. M., Eichele G. Complementary domains of retinoic acid production and degradation in the early chick embryo. Dev. Biol. 1999; 216(1)282–296, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tang W. K., Cheng C. H., Fong W. P. First purification of the antiquitin protein and demonstration of its enzymatic activity. FEBS Lett. 2002; 516(1–3)183–186, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Thukkani A. K., McHowat J., Hsu F. F., Brennan M. L., Hazen S. L., Ford D. A. Identification of alpha‐chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 2003; 108(25)3128–3133, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Totan Y., Cekic O., Borazan M., Uz E., Sogut S., Akyol O. Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. Br. J. Ophthalmol. 2001; 85(12)1426–1428, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Townsend A. J., Leone‐Kabler S., Haynes R. L., Wu Y., Szweda L., Bunting K. D. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells. Chem. Biol. Interact. 2001; 130–132(1–3)261–273, [CROSSREF]
- Traverso N., Menini S., Odetti P., Pronzato M. A., Cottalasso D., Marinari U. M. Lipoperoxidation in hepatic subcellular compartments of diabetic rats. Free Radic. Biol. Med. 1999; 26(5–6)538–547, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Traverso N., Menini S., Odetti P., Pronzato M. A., Cottalasso D., Marinari U. M. Diabetes impairs the enzymatic disposal of 4‐hydroxynonenal in rat liver. Free Radic. Biol. Med. 2002; 32(4)350–359, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ueshima Y., Matsuda Y., Tsutsumi M., Takada A. Role of the aldehyde dehydrogenase‐1 isozyme in the metabolism of acetaldehyde. Alcohol Alcohol., Suppl. 1993; 1B: 15–19, [CSA]
- Valle D., Goodman S. I., Applegarth D. A., Shih V. E., Phang J. M. Type II hyperprolinemia. Delta1‐pyrroline‐5‐carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes. J. Clin. Invest. 1976; 58(3)598–603, [PUBMED], [INFOTRIEVE]
- Vasiliou V., Pappa A. Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. Pharmacology 2000; 61(3)192–198, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vasiliou V., Puga A., Nebert D. W. Negative regulation of the murine cytosolic aldehyde dehydrogenase‐3 (Aldh‐3c) gene by functional CYP1A1 and CYP1A2 proteins. Biochem. Biophys. Res. Commun. 1992; 187(1)413–419, [PUBMED], [INFOTRIEVE]
- Vasiliou V., Shertzer H. G., Liu R. M., Sainsbury M., Nebert D. W. Response of [Ah] battery genes to compounds that protect against menadione toxicity. Biochem. Pharmacol. 1995; 50(11)1885–1891, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vasiliou V., Bairoch A., Tipton K. F., Nebert D. W. Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping. Pharmacogenetics 1999; 9(4)421–434, [PUBMED], [INFOTRIEVE], [CSA]
- Vasiliou V., Pappa A., Petersen D. R. Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem. Biol. Interact. 2000; 129(1–2)1–19, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vaz F. M., Fouchier S. W., Ofman R., Sommer M., Wanders R. J. Molecular and biochemical characterization of rat gamma‐trimethylaminobutyraldehyde dehydrogenase and evidence for the involvement of human aldehyde dehydrogenase 9 in carnitine biosynthesis. J. Biol. Chem. 2000; 275(10)7390–7394, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vermot J., Niederreither K., Garnier J. M., Chambon P., Dolle P. Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice. Proc. Natl. Acad. Sci. U. S. A. 2003; 100(4)1763–1768, [PUBMED], [INFOTRIEVE], [CSA]
- Wang X., Penzes P., Napoli J. L. Cloning of a cDNA encoding an aldehyde dehydrogenase and its expression in Escherichia coli. Recognition of retinal as substrate. J. Biol. Chem. 1996; 271(27)16288–16293, [PUBMED], [INFOTRIEVE]
- Willemsen M. A., Rotteveel J. J., van Domburg P. H., Gabreels F. J., Mayatepek E., Sengers R. C. Preterm birth in Sjögren–Larsson syndrome. Neuropediatrics 1999; 30(6)325–327, [PUBMED], [INFOTRIEVE], [CSA]
- Willemsen M. A., IJlst L., Steijlen P. M., Rotteveel J. J., de Jong J. G., van Domburg P. H., Mayatepek E., Gabreels F. J., Wanders R. J. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren–Larsson syndrome. Brain 2001; 124(Pt. 7)1426–1437, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Witztum J. L. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344(8925)793–795, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Xiao C., Xin H., Dong A., Sun C., Cao K. A novel calmodulin‐like protein gene in rice which has an unusual prolonged C‐terminal sequence carrying a putative prenylation site. DNA Res. 1999; 6(3)179–181, [PUBMED], [INFOTRIEVE], [CSA]
- Yamada Y., Sun F., Tsuritani I., Honda R. Genetic differences in ethanol metabolizing enzymes and blood pressure in Japanese alcohol consumers. J. Hum. Hypertens. 2002; 16(7)479–486, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yeh G. C., Roth E. F., Jr., Phang J. M., Harris S. C., Nagel R. L., Rinaldi A. The effect of pyrroline‐5‐carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose‐6‐phosphate dehydrogenase‐deficient subjects. J. Biol. Chem. 1984; 259(9)5454–5458, [PUBMED], [INFOTRIEVE]
- Yokoyama A., Omori T. Alcohol and oropharyngolaryngeal and digestive tract cancer. Nihon Arukoru, Yakubutsu Igakkai Zasshi 2001; 36(6)551–566
- Yokoyama A., Muramatsu T., Ohmori T., Yokoyama T., Okuyama K., Takahashi H., Hasegawa Y., Higuchi S., Maruyama K., Shirakura K., Ishii H. Alcohol‐related cancers and aldehyde dehydrogenase‐2 in Japanese alcoholics. Carcinogenesis 1998a; 19(8)1383–1387, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yokoyama A., Ohmori T., Muramatsu T., Yokoyama T., Okuyama K., Makuuchi H., Takahashi H., Higuchi S., Hayashida M., Maruyama K., Ishii H. Short‐term follow‐up after endoscopic mucosectomy of early esophageal cancer and aldehyde dehydrogenase‐2 genotype in Japanese alcoholics. Cancer Epidemiol. Biomark. Prev. 1998b; 7(6)473–476, [CSA]
- Yokoyama A., Muramatsu T., Omori T., Matsushita S., Yoshimizu H., Higuchi S., Yokoyama T., Maruyama K., Ishii H. Alcohol and aldehyde dehydrogenase gene polymorphisms influence susceptibility to esophageal cancer in Japanese alcoholics. Alcohol., Clin. Exp. Res. 1999; 23(11)1705–1710, [CSA]
- Yokoyama A., Muramatsu T., Omori T., Yokoyama T., Matsushita S., Higuchi S., Maruyama K., Ishii H. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 2001; 22(3)433–439, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yoshida A. Molecular genetics of human aldehyde dehydrogenase. Pharmacogenetics 1992; 2(4)139–147, [PUBMED], [INFOTRIEVE]
- Yoshida A., Huang I. Y., Ikawa M. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc. Natl. Acad. Sci. U. S. A. 1984; 81(1)258–261, [PUBMED], [INFOTRIEVE]
- Ziegler T. L., Vasiliou V. Aldehyde dehydrogenase gene superfamily. The 1998 update. Adv. Exp. Med. Biol. 1999; 463: 255–263, [PUBMED], [INFOTRIEVE], [CSA]